dimanche 15 novembre 2026
RechercherExplore
fr.via.news
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· March 23, 2026

Once-in-a-Decade Opportunity: 1 AI Software Stock to Buy While It's Still Down

View original at nasdaq.com
Once-in-a-Decade Opportunity: 1 AI Software Stock to Buy While It's Still Down Key Points Salesforce's AI business is scaling rapidly, with Agentforce reaching annual recurring revenue of $800 million…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Salesforce stock seems like a smart buy now considering its relatively modest valuation alongside improving AI-powered growth indicators

    60% confidence

  • Stock Advisor's total average return is 898%, compared to 183% for the S&P 500

    60% confidence

  • More than 60% of Agentforce and Data 360 bookings were from existing customers

    60% confidence

  • Salesforce expects organic subscription and support revenue growth to reaccelerate in the second half of fiscal 2027

    60% confidence

  • The 10 best stocks for investors to buy now do not include Salesforce

    60% confidence

  • All the top 10 deals secured by Salesforce in the fourth quarter included Agentforce

    60% confidence

Data points we hold from this source

Salesforce · remaining performance obligations72.4 USD
Salesforce · current rpo growth16 percent
Salesforce · current rpo35.1 USD
Salesforce · agentforce data360 arr growth200 percent
Salesforce · agentforce data360 combined arr2.9 USD
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,997
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,997 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Once-in-a-Decade Opportunity: 1 AI Software Stock to Buy While It's Still Down: Source | Via News | fr.via.news